Bond.az White LogoBond.az Black Logo

Rocket Lab completes 9th mission for Synspective

Rocket Lab launches 9th StriX satellite for Synspective, expanding Earth observation constellation. Mission success rate remains 100%.

Julianne Alice
ByJulianne Alice- Senior Editor
|
0

Rocket Lab Corporation (NASDAQ:RKLB) has successfully launched its ninth satellite for Synspective. The StriX satellite was deployed into a 572km low Earth orbit from Launch Complex 1 in New Zealand at 9:33 p.m. NZST.

The mission, named Viva La StriX, expands Synspective's synthetic aperture radar constellation, which provides Earth observation data. The Japan-based company operates an Earth observation satellite network.

Rocket Lab provided a custom fairing for the Electron rocket tailored to the StriX satellite's dimensions. The company stated this customization has contributed to maintaining a 100% mission success rate for StriX satellite deployments.

The launch marks Rocket Lab's 88th mission. Synspective has booked 18 additional launches with Rocket Lab, making the company its sole launch provider.

This successful deployment comes as Rocket Lab's stock has surged 386% over the past year, trading at $125.45 with a market capitalization of $72 billion. Bond.az highlights that analysts anticipate sales growth in the current year, with revenue expected to grow 52%.

Rocket Lab operates the Electron rocket for small satellite launches and is developing a medium-lift vehicle called Neutron. The company also manufactures spacecraft and satellite components.

More News
2026-06-01 12:34
|
401

Amber International shareholder to distribute stake pro rata

Amber International's principal shareholder distributes all Class A shares pro rata to existing shareholders; market impact and financial highlights.

0
2026-06-01 12:33
|
213

Palladyne AI Adds Two Retired Generals to Board

Palladyne AI appoints two retired generals to its defense advisory board. Stock up 98% YTD.

0
2026-06-01 12:32
|
381

Cellectar Plans Phase 3 Trial for WM After BTKi

Cellectar Biosciences reports promising Phase 2 results for iopofosine I 131 in Waldenström macroglobulinemia after BTKi therapy, plans Phase 3 trial.

0
2026-06-01 11:33
|
363

essensys Shareholders Approve Re-Registration as Private Company

essensys shareholders approve re-registration as a private company after AIM delisting. All voting shareholders backed the resolution.

0
2026-06-01 08:31
|
890

Causeway Capital Boosts Melrose Stake to 5.12%

Causeway Capital increased its stake in Melrose Industries to 5.12%. The investment firm now holds over 63 million voting rights.

0
2026-06-01 08:03
|
968

Ignitis grupė starts search for new CEO

Ignitis grupė launches CEO search in Lithuania. Learn about requirements and application deadline for the new CEO position.

0
2026-06-01 07:33
|
417

Aquila Renewables: Adviser Withholds Fee Data

Aquila European Renewables says its investment adviser Aquila Capital has not provided complete fee information. The Board is considering legal action.

0
2026-06-01 07:31
|
226

USA Rare Earth Plans €175M France Investment

USA Rare Earth reveals €175 million investment plan in France for metal, alloy and magnet manufacturing, aiming to create over 300 jobs by 2030.

0
2026-06-01 07:30
|
762

Lucid Group Names Silvio Napoli CEO

Lucid Group appoints Silvio Napoli as CEO effective immediately. Stock up 12% in past week but down 38% YTD. Company faces financial challenges.

0
2026-06-01 07:04
|
680

Mkango Reports Q1 2026 Financial Results

Mkango Resources reports Q1 2026 financial results. Details on rare earth projects, recycling operations, and SPAC merger.

0
2026-06-01 07:02
|
274

Greatland secures $500m debt facility, OKs Havieron

Greatland Resources secures $500 million corporate debt facility and board approval for Havieron gold-copper project final investment decision.

0
2026-06-01 07:00
|
543

Calnex director buys shares at 69.9p

Calnex Solutions non-executive director Graeme Bissett buys 28,610 shares at 69.9p each on the London Stock Exchange.

0
...